​

Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

OverviewForecastRevenueFinancialsChart

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 68.35% institutional investors, and 31.65% retail investors. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJasper Therapeutics68.35%-31.65%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202339-7.14%74,996,253-18.08%680.97%17-928.57%
Sep 30, 202342-14.29%91,546,6023.92%830.84%17-10.53%7-30.00%
Jun 30, 202349-3.92%88,090,697-5.98%990.88%19-57.78%10900.00%
Mar 31, 202351121.74%93,692,255362.76%10620.15%45350.00%1-83.33%
Dec 31, 20222321.05%20,246,590-0.44%224.32%1011.11%6200.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc581.54K3.85%-
Vanguard Total Stock Mkt Idx Inv401.22K2.67%-
Franklin Biotechnology Discv A(acc)USD367.37K2.45%-
iShares Russell 2000 ETF296.68K1.96%-672.00
HBM Healthcare Investments AG Ord250.00K1.66%-
Franklin Biotechnology Discovery A212.24K1.41%-24.60K
Vanguard Institutional Extnd Mkt Idx Tr188.66K1.26%-
DWS ESG Biotech LC125.00K0.83%45.00K
Fidelity Small Cap Index115.36K0.76%-3.43K
iShares Russell 2000 Growth ETF100.34K0.66%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$19.90K
Sep 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$19.10K
Jun 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$21.74K
Mar 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$23.79K
Feb 08, 2024Carlyle Group Inc. Former 10% OwnerBuy$2.46M

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q2-1
2024 Q121
2023 Q451

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 68.35%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 47.04%, which Jasper Therapeutics exceeds.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools